Thanks for informing us about what “actually happened,” but you’re actually wrong 😶
To clarify the mis- or disinformation, & for details about the DCVax®-L PIII clinical trial, the most comprehensive resource is the independent peer review that was published in JAMA Oncology.
☑️ There are multiple trials & trial designs relevant to NWBO that include either a DCVax product or Roswell’s aDC1 platform.
☑️ Beyond the PIII ECA, DCVax®-L is also being studied in a RCT setting with placebo group.
It was 2 weeks before data lock. So I used "virtually" for simplicity. But bottom line it was 12 YEARS after they were supposed to have proposed, designed and gotten approval for the ECA.
Market Data 
Markets 
AI
